Metabolomics

, Volume 10, Issue 5, pp 995–1004

Metabolomic analysis of the effects of omeprazole and famotidine on aspirin-induced gastric injury

  • Kenichiro Takeuchi
  • Maki Ohishi
  • Keiko Endo
  • Kenichi Suzumura
  • Hitoshi Naraoka
  • Takeji Ohata
  • Jiro Seki
  • Yoichi Miyamae
  • Masashi Honma
  • Tomoyoshi Soga
Original Article

DOI: 10.1007/s11306-014-0627-0

Cite this article as:
Takeuchi, K., Ohishi, M., Endo, K. et al. Metabolomics (2014) 10: 995. doi:10.1007/s11306-014-0627-0

Abstract

Gastric mucosal ulceration and gastric hemorrhage are frequently associated with treatment by non-steroid anti-inflammatory drugs (NSAIDs); however, no convenient biomarker-based diagnostic methods for these adverse reactions are currently available, requiring the use of endoscopic evaluation. We recently reported five biomarker candidates in serum which predict gastric injury induced by NSAIDs in rats, but were unable to clarify the mechanism of change in the levels of these biomarker candidates. In this study, we performed capillary electrophoresis–mass spectrometry-based metabolomic profiling in stomach and serum from rats in which gastric ulcer was induced by aspirin and prevented by co-administration of omeprazole and famotidine. Results showed drug-induced decreases in the levels of citrate, cis-aconitate, succinate, 3-hydroxy butanoic acid, and O-acetyl carnitine in all animals administered aspirin. In contrast, aspirin-induced decreases in the level of 4-hydroxyproline were suppressed by co-administration of omeprazole and famotidine. We consider that these changes were due to the prevention of gastric ulcer and decrease in the amount of collagen in stomach tissue by omeprazole and famotidine, without prevention of the NSAID-induced depression of mitochondrial function. In addition, the decreases in 4-hydroxyproline in the stomach was also detectable as changes in the serum. While further study is needed to clarify limitations of indications and extrapolation to humans, this new serum biomarker candidate of gastric injury may be useful in the monitoring of NSAID-induced tissue damage.

Keywords

Metabolomics Capillary electrophoresis–mass spectrometry (CE–MS) Gastric injury Non-steroid anti-inflammatory drugs (NSAIDs) Omeprazole Famotidine 

Supplementary material

11306_2014_627_MOESM1_ESM.pdf (199 kb)
Supplementary material 1 (PDF 198 kb)
11306_2014_627_MOESM2_ESM.pdf (195 kb)
Supplementary material 2 (PDF 194 kb)
11306_2014_627_MOESM3_ESM.pdf (14 kb)
Supplementary material 3 (PDF 14 kb)
11306_2014_627_MOESM4_ESM.pdf (122 kb)
Supplementary material 4 (PDF 121 kb)
11306_2014_627_MOESM5_ESM.pdf (173 kb)
Supplementary material 5 (PDF 172 kb)
11306_2014_627_MOESM6_ESM.pdf (14 kb)
Supplementary material 6 (PDF 14 kb)

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Kenichiro Takeuchi
    • 1
  • Maki Ohishi
    • 2
  • Keiko Endo
    • 2
  • Kenichi Suzumura
    • 3
  • Hitoshi Naraoka
    • 1
  • Takeji Ohata
    • 1
  • Jiro Seki
    • 1
  • Yoichi Miyamae
    • 1
  • Masashi Honma
    • 4
  • Tomoyoshi Soga
    • 2
  1. 1.Drug Safety Research LaboratoriesAstellas Pharma Inc.OsakaJapan
  2. 2.Institute for Advanced BioscienceKeio UniversityTsuruokaJapan
  3. 3.Analysis and Pharmacokinetics Research LaboratoriesAstellas Pharma Inc.Tsukuba-shiJapan
  4. 4.Department of PharmacyThe University of Tokyo HospitalTokyoJapan

Personalised recommendations